University of Essex
Colchester, Essex, CO4 3SQ, United Kingdom
NCT Number: NCT07532967
This study investigates how the design of web links in digital vaccination invitation emails affects recipient trust and their willingness to book an appointment. Researchers compare three different weblink formats: a control third-party link previously used by the NHS ("accurx"), and two experimental weblinks in which the original link is hidden: a shortened "bit.ly" link, and a text-embedded hyperlink.
The study primarily tests whether the two experimental weblinks will be perceived as more trustworthy and increase booking intention compared to the control weblink. Furthermore, the study examines whether the experimental weblinks is perceived to be more fluent (easier to read) and improves participants' ability to correctly identify the organisation (e.g., the NHS or a US pharmacy) that sent the hypothetical email.
To test these effects, investigators will gather data from 600 participants from the United Kingdom and 600 from the United States. They will be randomly assigned to view one of the three hypothetical email versions. UK participants will see emails appearing to be from the NHS, while US participants will see emails from a fictitious pharmacy (Pharma-US). This research aims to provide evidence on how to design more effective and trustworthy digital health communications.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Colchester, Essex, CO4 3SQ, United Kingdom
This randomised experimental study investigates how weblink design influences the perceived trustworthiness of digital health communications. As digital invitations (e.g., emails and SMS) have become standard for public health initiatives such as vaccination programs, the use of third-party or disfluent (hard-to-read) web links may inadvertently undermine trust.
Study Protocol and Intervention
Participants will be randomly allocated to one of three experimental conditions. In all conditions, participants will read a hypothetical email invitation for a COVID-19 booster vaccine. The content of the emails remains identical except for the format of the booking weblink included in the email:
Control Condition: Features the "accurx" web link (accurx.thirdparty.nhs.uk/r/aafwaczmd5) based on a third-party format used in official invitations from the UK's NHS.
Experimental Condition 1: (Concealed in shortened URL) features a shortened version of the link using a bit.ly domain.
Experimental Condition 2: (Concealed, text-embedded) shows the link presented as a descriptive hyperlink.
To ensure relevance to the target populations, participants will see a version of the hypothetical email tailored to their country of residence: UK participants will see invitations sent from the NHS, while US participants will see invitations from a fictitious pharmacy (Pharma-US). Unlike the UK, COVID-19 vaccination in the US was predominantly organised by local pharmacies.
Primary Hypotheses
The study was designed to test six primary hypotheses:
Measurement
Following the presentation of the hypothetical email, participants will rate the email on three 5-point Likert scales: trustworthiness (1: Very suspicious to 5: Very trustworthy), fluency (1: Very difficult to 5: Very easy), and booking intention (1: Very unlikely to 5: Very likely). Host identification will be assessed via a multiple-choice question with four options: the NHS, Pharma-US, Accurx, or 'Not sure'.
The investigators will aim to gather data from 600 participants from the UK and 600 from the US. They will be invited to complete the study via an online platform. Participants who complete the study too fast or failed the attention check will be excluded.
This study will be conducted as part of a larger research project exploring the broader relationship between the trustworthiness of digital messages and national vaccination rates.
The study hypotheses, design, measures and analyses were preregistered before the start of data collection on a different platform (AsPredicted). This time stamped preregistration protocol is linked as a document in this registration.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention involved presenting a hypothetical invitation to a COVID-19 booster vaccination via email. Participants were randomly allocated to view one of three versions of the invitation to evaluate how the specific design of the embedded weblink influences recipient trust and booking behaviour.
To ensure local relevance, the email stimulus was adapted based on the participant's country of residence: participants in the United Kingdom saw invitations that appeared to be from the NHS, while those in the United States saw invitations that appeared to be from a fictitious pharmacy, Pharma-US. Following the intervention, participants evaluated the email's trustworthiness, the link's fluency, and their own intention to book a vaccine appointment.
Time frame: Immediately after the intervention
Participants rated the perceived trustworthiness of the vaccination invitation email on a 5-point Likert scale, where 1 represents "Very suspicious", and 5 represents "Very trustworthy".
Time frame: Immediately after the intervention
Participants rated their likelihood of booking a vaccine appointment based on the email invitation using a 5-point Likert scale ranging from 1 ("Very unlikely") to 5 ("Very likely").
Time frame: Immediately after the intervention
Participants assessed the reading ease (or fluency) of the embedded weblink on a 5-point Likert scale, where 1 is "Very difficult", and 5 is "Very easy".
Time frame: Immediately after the intervention
Participants were asked to identify the organisation that sent the communication by selecting one answer from a multiple-choice list of four options: the NHS, Pharma-US, Accurx, or Unclear/I don't know.
University of Essex
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03587610
Vaccination
Le Mans, France
View Trial DetailsNCT01054053
Vaccination
Neufchâtel-en-Bray, France
View Trial DetailsNCT07007377
Flu, Flu-like Symptoms
São Paulo, Brazil
View Trial DetailsNCT04936776
Hematologic Diseases, Hemic and Lymphatic Diseases
New York, United States
View Trial Details